Gao L, Cheng Z, Ma G, et al. Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 study. J Diabetes Investig. Published online November 21, 2025. doi:10.1111/jdi.70175